The first was substances with enough of a safety track record that the agency felt comfortable letting compounders use them while the final list was assembled
Although both peptides are involved in regenerative processes, their biological mechanisms are complementary rather than identical
While more human research is needed, current user feedback and practitioner insights suggest the following best practices: Standard Dosage Most users take 50100 mg per day , typically in divided doses (e.g., 2550 mg twice daily) to maintain stable blood levels
Colchicine In the past, high doses of colchicine were used for gout attacks, but this tended to cause diarrhea in a large number of patients
Nodules from BPC-157 resolve without treatment within two to three days
Highdose IV protocols (5001,500 mg daily for ~10 days) have been used in openlabel studies for substance use disorder, with reports of reduced cravings and improved mood in followups [2] [9]